ID   ICK_HUMAN               Reviewed;         632 AA.
AC   Q9UPZ9; A7MD41; O75985; Q5THL2; Q8IYH8; Q9BX17; Q9NYX3;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   02-NOV-2010, entry version 90.
DE   RecName: Full=Serine/threonine-protein kinase ICK;
DE            EC=2.7.11.22;
DE   AltName: Full=Intestinal cell kinase;
DE            Short=hICK;
DE   AltName: Full=Laryngeal cancer kinase 2;
DE            Short=LCK2;
DE   AltName: Full=MAK-related kinase;
DE            Short=MRK;
GN   Name=ICK; Synonyms=KIAA0936;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ENZYME REGULATION,
RP   TISSUE SPECIFICITY, MUTAGENESIS OF LYS-33; LYS-34; LYS-36; LYS-38;
RP   THR-157 AND TYR-159, AND PHOSPHORYLATION AT THR-157 AND TYR-159.
RC   TISSUE=Colon;
RX   PubMed=10699974;
RX   DOI=10.1002/(SICI)1097-4652(200004)183:1<129::AID-JCP15>3.3.CO;2-J;
RA   Togawa K., Yan Y.-X., Inomoto T., Slaugenhaupt S.A., Rustgi A.K.;
RT   "Intestinal cell kinase (ICK) localizes to the crypt region and
RT   requires a dual phosphorylation site found in map kinases.";
RL   J. Cell. Physiol. 183:129-139(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=12103360; DOI=10.1016/S1389-0344(02)00002-3;
RA   Yang T., Jiang Y., Chen J.;
RT   "The identification and subcellular localization of human MRK.";
RL   Biomol. Eng. 19:1-4(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   MEDLINE=99246063; PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-156 AND TYR-159, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-156; THR-157; TYR-159;
RP   TYR-583 AND SER-584, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] TYR-115; ILE-320; LYS-471; GLN-476 AND
RP   THR-615.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [10]
RP   VARIANT ECO GLN-272, CHARACTERIZATION OF VARIANT ECO GLN-272, AND
RP   POSSIBLE FUNCTION.
RX   PubMed=19185282; DOI=10.1016/j.ajhg.2008.12.017;
RA   Lahiry P., Wang J., Robinson J.F., Turowec J.P., Litchfield D.W.,
RA   Lanktree M.B., Gloor G.B., Puffenberger E.G., Strauss K.A.,
RA   Martens M.B., Ramsay D.A., Rupar C.A., Siu V., Hegele R.A.;
RT   "A multiplex human syndrome implicates a key role for intestinal cell
RT   kinase in development of central nervous, skeletal, and endocrine
RT   systems.";
RL   Am. J. Hum. Genet. 84:134-147(2009).
CC   -!- FUNCTION: May play a key role in the development of multiple organ
CC       systems and particularly in cardiac development (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm, cytosol (By similarity).
CC       Note=Nuclear localization has been observed with a GFP-tagged
CC       construct in transfected HeLa cells (PubMed:12103360). Cytosolic
CC       localization was shown in rat embryonic cardiomyocytes by
CC       immunostaining (PubMed:8570168).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UPZ9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UPZ9-2; Sequence=VSP_050752, VSP_050753;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Expressed in heart, brain, placenta, pancreas,
CC       thymus, prostate, testis, ovary, small intestine and colon, with
CC       highest levels in placenta and testis. Not detected in spleen.
CC       Also expressed in many cancer cell lines.
CC   -!- PTM: Autophosphorylated on serine and threonine residues. May play
CC       a role in enzyme activation.
CC   -!- DISEASE: Defects in ICK are the cause of endocrine-
CC       cerebroosteodysplasia (ECO) [MIM:612651]. ECO is a previously
CC       unidentified neonatal lethal recessive disorder with multiple
CC       anomalies involving the endocrine, cerebral, and skeletal systems.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA76780.2; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF225919; AAF37278.1; -; mRNA.
DR   EMBL; AF152469; AAG43364.1; -; mRNA.
DR   EMBL; AB023153; BAA76780.2; ALT_INIT; mRNA.
DR   EMBL; AL031178; CAI20261.1; -; Genomic_DNA.
DR   EMBL; AL162581; CAI20261.1; JOINED; Genomic_DNA.
DR   EMBL; AL162581; CAI19518.1; -; Genomic_DNA.
DR   EMBL; AL031178; CAI19518.1; JOINED; Genomic_DNA.
DR   EMBL; CH471081; EAX04400.1; -; Genomic_DNA.
DR   EMBL; BC035807; AAH35807.1; -; mRNA.
DR   EMBL; BC136420; AAI36421.1; -; mRNA.
DR   EMBL; BC136421; AAI36422.1; -; mRNA.
DR   EMBL; BC152464; AAI52465.1; -; mRNA.
DR   IPI; IPI00217776; -.
DR   IPI; IPI00414132; -.
DR   RefSeq; NP_055735.1; -.
DR   RefSeq; NP_057597.2; -.
DR   UniGene; Hs.417022; -.
DR   ProteinModelPortal; Q9UPZ9; -.
DR   SMR; Q9UPZ9; 1-285.
DR   MINT; MINT-1200416; -.
DR   STRING; Q9UPZ9; -.
DR   PhosphoSite; Q9UPZ9; -.
DR   PRIDE; Q9UPZ9; -.
DR   Ensembl; ENST00000350082; ENSP00000263043; ENSG00000112144.
DR   Ensembl; ENST00000356971; ENSP00000349458; ENSG00000112144.
DR   GeneID; 22858; -.
DR   KEGG; hsa:22858; -.
DR   UCSC; uc003pbh.2; human.
DR   UCSC; uc003pbj.1; human.
DR   CTD; 22858; -.
DR   GeneCards; GC06M052912; -.
DR   H-InvDB; HIX0200827; -.
DR   HGNC; HGNC:21219; ICK.
DR   HPA; HPA001113; -.
DR   MIM; 612325; gene.
DR   MIM; 612651; phenotype.
DR   Orphanet; 199332; Endocrine-cerebro-osteodysplasia syndrome.
DR   PharmGKB; PA134894544; -.
DR   eggNOG; prNOG19551; -.
DR   HOGENOM; HBG445725; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; Q9UPZ9; -.
DR   OMA; CIMAEVY; -.
DR   OrthoDB; EOG9S4S1B; -.
DR   PhylomeDB; Q9UPZ9; -.
DR   BRENDA; 2.7.11.22; 247.
DR   NextBio; 43345; -.
DR   ArrayExpress; Q9UPZ9; -.
DR   Bgee; Q9UPZ9; -.
DR   CleanEx; HS_ICK; -.
DR   Genevestigator; Q9UPZ9; -.
DR   GermOnline; ENSG00000112144; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0004693; F:cyclin-dependent protein kinase activity; IEA:EC.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:UniProtKB.
DR   GO; GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Developmental protein; Disease mutation; Kinase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    632       Serine/threonine-protein kinase ICK.
FT                                /FTId=PRO_0000086007.
FT   DOMAIN        4    284       Protein kinase.
FT   NP_BIND      10     18       ATP (By similarity).
FT   ACT_SITE    125    125       Proton acceptor (By similarity).
FT   BINDING      33     33       ATP.
FT   MOD_RES      14     14       Phosphothreonine (By similarity).
FT   MOD_RES      15     15       Phosphotyrosine (By similarity).
FT   MOD_RES     156    156       Phosphotyrosine.
FT   MOD_RES     157    157       Phosphothreonine.
FT   MOD_RES     159    159       Phosphotyrosine.
FT   MOD_RES     583    583       Phosphotyrosine.
FT   MOD_RES     584    584       Phosphoserine.
FT   VAR_SEQ     278    292       ALRYPYFQVGHPLGS -> VFFHFLVITFISNSE (in
FT                                isoform 2).
FT                                /FTId=VSP_050752.
FT   VAR_SEQ     293    632       Missing (in isoform 2).
FT                                /FTId=VSP_050753.
FT   VARIANT      98     98       P -> L (in dbSNP:rs1493105).
FT                                /FTId=VAR_053931.
FT   VARIANT     115    115       F -> Y (in a renal clear cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042001.
FT   VARIANT     272    272       R -> Q (in ECO; fails to localize at the
FT                                nucleus and significantly impairs kinase
FT                                activity).
FT                                /FTId=VAR_057994.
FT   VARIANT     320    320       V -> I (in dbSNP:rs33936662).
FT                                /FTId=VAR_042002.
FT   VARIANT     471    471       T -> K (in dbSNP:rs56164633).
FT                                /FTId=VAR_042003.
FT   VARIANT     476    476       R -> Q (in dbSNP:rs55895113).
FT                                /FTId=VAR_042004.
FT   VARIANT     615    615       A -> T (in dbSNP:rs55932059).
FT                                /FTId=VAR_042005.
FT   MUTAGEN      33     33       K->R: Loss of activity and
FT                                autophosphorylation; when associated with
FT                                R-34; R-36 and R-38.
FT   MUTAGEN      34     34       K->R: Loss of activity and
FT                                autophosphorylation; when associated with
FT                                R-33; R-36 and R-38.
FT   MUTAGEN      36     36       K->R: Loss of activity and
FT                                autophosphorylation; when associated with
FT                                R-33; R-34 and R-38.
FT   MUTAGEN      38     38       K->R: Loss of activity and
FT                                autophosphorylation; when associated with
FT                                R-33; R-34 and R-36.
FT   MUTAGEN     157    157       T->A: Reduction of activity and loss of
FT                                autophosphorylation. Loss of activity and
FT                                autophosphorylation; when associated with
FT                                F-159.
FT   MUTAGEN     159    159       Y->F: Reduction of activity and loss of
FT                                autophosphorylation. Loss of activity and
FT                                autophosphorylation; when associated with
FT                                A-157.
FT   CONFLICT     48     48       L -> Q (in Ref. 1; AAF37278).
FT   CONFLICT    119    119       H -> L (in Ref. 1; AAF37278).
FT   CONFLICT    310    310       K -> R (in Ref. 1; AAF37278).
FT   CONFLICT    598    599       FH -> LD (in Ref. 1; AAF37278).
FT   CONFLICT    629    629       A -> P (in Ref. 1; AAF37278).
SQ   SEQUENCE   632 AA;  71427 MW;  F4C22C6CCD5878D2 CRC64;
     MNRYTTIRQL GDGTYGSVLL GRSIESGELI AIKKMKRKFY SWEECMNLRE VKSLKKLNHA
     NVVKLKEVIR ENDHLYFIFE YMKENLYQLI KERNKLFPES AIRNIMYQIL QGLAFIHKHG
     FFHRDLKPEN LLCMGPELVK IADFGLAREI RSKPPYTDYV STRWYRAPEV LLRSTNYSSP
     IDVWAVGCIM AEVYTLRPLF PGASEIDTIF KICQVLGTPK KTDWPEGYQL SSAMNFRWPQ
     CVPNNLKTLI PNASSEAVQL LRDMLQWDPK KRPTASQALR YPYFQVGHPL GSTTQNLQDS
     EKPQKGILEK AGPPPYIKPV PPAQPPAKPH TRISSRQHQA SQPPLHLTYP YKAEVSRTDH
     PSHLQEDKPS PLLFPSLHNK HPQSKITAGL EHKNGEIKPK SRRRWGLISR STKDSDDWAD
     LDDLDFSPSL SRIDLKNKKR QSDDTLCRFE SVLDLKPSEP VGTGNSAPTQ TSYQRRDTPT
     LRSAAKQHYL KHSRYLPGIS IRNGILSNPG KEFIPPNPWS SSGLSGKSSG TMSVISKVNS
     VGSSSTSSSG LTGNYVPSFL KKEIGSAMQR VHLAPIPDPS PGYSSLKAMR PHPGRPFFHT
     QPRSTPGLIP RPPAAQPVHG RTDWASKYAS RR
//
